MedTrace Logo

Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea

NCT05814042 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 396

Last updated 2026-04-14

Study results available
· View outcomes & findings →

Summary

Diarrhea remains a leading killer of children in need of better treatments.

Conditions

Interventions

DRUG

Next Generation ORS (oral rehydration solution) (including placebo

Nutrition used to stop diarrhea

DRUG

Current standard control ORS (oral rehydration solution)

current standard control ORS in diarrheic patients with cholera

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • University of Florida

    lead OTHER

Principal Investigators

  • Sam Cheng, MD. PhD · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-21
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Bangladesh

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05814042 on ClinicalTrials.gov